Akara raises $5.5M to scale privacy-preserving hospital AI

Akara, a health-tech company spun out of Trinity College Dublin, announced on Nov. 11 that it raised $5.5M in a round led by health-focused VC firm Locke Health, with participation from VTC Ventures, EIC Fund, CommonKind and NovaVector Holdings, plus existing backers ACT, Atlantic Bridge and Enterprise Ireland, according to the company's GlobeNewswire release. The raise brings Akara's total funding to $12.3M. Silicon Republic's reporting confirms the round and adds detail on the technology: thermal imaging paired with edge AI lets Akara's sensors capture how clinical space is used — patient flow, bed turnover, staff movement — without recording identifiable video of patients or staff, and without requiring hospitals to overhaul existing IT infrastructure.

CEO Conor McGinn said the goal is to "give staff time back and help hospitals treat more patients." The system already runs in hospitals across Ireland, the UK and the U.S.; the new funding goes toward accelerating hospital adoption and, notably, expanding Akara's engineering team to extend its AI agents into more healthcare workflows — which is where most companies at this stage hit a wall.

Privacy-by-design is a software decision, not a sensor spec

Hospital compliance teams aren't sold on the thermal camera. They're sold on the fact that the privacy guarantee lives in the architecture, not a policy document. Processing activity data on-device, rather than streaming raw frames to the cloud, means there's no central video repository to breach, subpoena or misconfigure. Building that takes real engineering work: inference models that run efficiently at the edge, a data model that can represent "occupancy" and "movement" without ever reconstructing a recognizable image, and an audit trail that proves the system never had identifiable data to lose in the first place. Getting that architecture past a hospital's security review usually takes longer than training the AI model did.

Why "expand the engineering team" is the headline, not a footnote

Akara's own framing of the raise is telling: the money is earmarked for hospital adoption and for growing operations and engineering in Ireland so the AI agents can cover more healthcare applications. That's the same bottleneck most funded healthtech startups hit post-Series-A — the clinical use case is proven, the next hospital wants a custom integration or a new agent behavior, and the founding engineering team can't build fast enough to keep pace with sales. Scaling past that point usually means bringing in specialized capacity rather than hiring a generalist team from scratch, which is exactly where a partner offering staff augmentation earns its keep: senior engineers who already understand HIPAA-adjacent data handling and edge-AI constraints can embed with a core team and ship the next integration without the six-month ramp of a cold hire.

Founders watching this round shouldn't take "raise $5.5M" as the lesson. The real one: this money is going toward engineering capacity about as much as the model itself, because getting privacy-preserving AI to actually work inside a hospital's existing workflow is an integration problem long before it's a data-science one.